POINT Biopharma Global Inc.: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$226.6M

Net Income/Loss (FY2022)

$98.3M

Total Assets (FY2022)

$578.3M

Total Equity (FY2022)

$487.0M

Cash Flows from Operating Activities (FY2022)

$183.5M

Source: POINT Biopharma Global Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.